Head and Neck Cancers

Latest News

Graphic reading "FDA Approved" resembling a stamp of approval
FDA Approves 2 Indications for Penpulimab-kcqx in Non-Keratinizing NPC

April 24th 2025

The FDA approved penpulimab-kcqx combination and monotherapy for non-keratinizing nasopharyngeal carcinoma.

Line illustration of a head, including the nasal cavity, mouth and throat on a gold background.
PYX-201 Receives FDA Fast Track Designation for Recurrent/Metastatic HNSCC

March 8th 2025

White line illustration of the head and neck, including the nasal cavity and throat, on a cornflower blue background
Petosemtamab/Pembrolizumab Receives FDA Breakthrough Designation for PD-L1+ HNSCC

February 28th 2025

Simple line illustration of a thyroid against a dark blue background
Thyroidectomy Without Radioiodine May Be Noninferior to Radioiodine Use in Thyroid Cancer

February 6th 2025

More News